Intellectual Burdens In Healthcare
Liberty is the foundation of American culture. But liberty in healthcare often handicaps patients who are less educated about their...
Eliminating the X Factor
The Department of Health and Human Services has eliminated the X-waiver requirement for physicians who prescribe opioid addiction medicine. We...
How Healthcare Gets Extreme
Healthcare is a balance, weighing different causes and effects, like an internal opportunity cost. But when the law simplifies the...
The Vaccine Is Not The Savior We Believe – But That Is Okay
The vaccine has arrived and the roll-out has begun, with many of the high-risk already vaccinated. But we should remain...
Can India Do The Impossible?
Within days India will begin one of the largest vaccine roll-outs in the world. Despite the enormous challenges that lie...
Special Report: Amicus Curiae Brief (USA v. Walmart Inc.)
Healthcare litigation surrounding the opioid epidemic has led to a slew of high-profile legal cases - with implications extending throughout...
Experiencing COVID-19 Firsthand
While most of the world was relaxing over the holidays, we at Daily Remedy were struggling with COVID-19. And we...
Has COVID-19 Made Us Smarter?
Living through a pandemic has undoubtedly made us more aware of our health and healthcare policy. But as we struggle...
The Vaccine is Here
The vaccine is here - and everything seems to be going wrong. We discuss some of the obstacles encountered and...
COVID-19’s Mental Constraints
The pandemic has proven how complex the relationship between healthcare policy and economics can be. However, the mental constraints may...
Mindfulness in Medical Decisions
Healthcare is a series of decisions, one after another. But most decisions are made reflexively, reiterating familiar patterns of thought....
Water, Water Everywhere
The editors write a heartfelt note thanking the readers for their support of the healthcare content and for their participation...
Videos
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more